Candicidin and Other Polyenic Antifungal Antibiotics a Review *

Total Page:16

File Type:pdf, Size:1020Kb

Candicidin and Other Polyenic Antifungal Antibiotics a Review * Bull. Org. mond. Sante 1965, 33, 219-226 Bull. Wid Hith Org. Candicidin and Other Polyenic Antifungal Antibiotics A Review * SELMAN A. WAKSMAN 1, HUBERT A. LECHEVALIER2 & CARL P. SCHAFFNER8 About 50 polyenic antifungal antibiotics produced by actinomycetes have been isolated and described. Among these are the most effective antimonilial agents so far known. These polyenes can be classified into four broad groups depending on the number of conjugated carbon-to-carbon double bonds that are present in their chromophores. Only some of the tetraenes (four conjugated double bonds), such as nystatin andpimaricin, and a few heptaenes (seven conjugated double bonds), such as amphotericin B, Trichomycin candicidin and hamycin, have found practical application in the treatment of infectious diseases caused by fungi. Nystatin and pimaricin show the least in vitro activity against fungi, while trichomycin and candicidin are the most active. Recent clinical investigations carried out in the USA have shown that candicidin is very effective in the treatment of vaginal monilial infections. In 1952, two of us in collaboration with two other substances can be divided into a number of groups members of the laboratory of the senior author of substances, the most important of which are the prepared for the Bulletin of the World Health polyenes. This group includes four subgroups: Organization a summary of what was then known the tetraenes, the pentaenes, the hexaenes, and the about antifungal antibiotics (Waksman et al., 1952). heptaenes. With the exception of nystatin, which is At that time, we suggested that two groups of such a tetraene, all the important antifungal polyenic substances could be recognized-namely, those agents from actinomycetes that have found practical that were active agai-nst fungi and bacteria and those application belong to the heptaenes. These are also that were active against fungi only. Of all the anti- the most frequently produced polyenes (Pledger & biotic-producing microbes, the actinomycetes were Lechevalier, 1956; Vanek et al., 1958; Oroshnik & shown to offer the greatest potentialities as sources Mebane, 1963). of antifungal agents. Six of the antibiotics listed The isolation of large numbers of antifungal were studied in further detail: fungicidin (now known antibiotics was made possible through various as nystatin), fradicin, cycloheximide (Actidione), screening programmes, using one or more fungi as antimycin A, and two numbered preparations, test organisms. Schatz & Hazen reported in 1948 C381 and C135. Antibiotic C135 was later named that, out of 243 cultures of actinomycetes isolated candicidin (Lechevalier et al., 1953). None of these from various soils, 124 (51 %) were antagonistic to preparations inhibited bacteria or actinomycetes, one or more of the following fungi: Candida albicans, but they exerted a marked effect upon the growth Cryptococcus neoformans, Trichophyton gypseum, of fungi, especially yeast forms. and T. rubrum. Ball et al. (1957) carried out an During the past fourteen years, an extensive extensive screening programme for antifungal literature has accumulated on the production of antibiotics, using soils collected from all parts of antifungal antibiotics by actinomycetes.4 These the world; the ratio of polyenic to non-polyenic antibiotics was 20: 1. * From the Institute of Microbiology, Rutgers-The State University of New Jersey, New Brunswick, N.J., USA. 1 Professor Emeritus, Microbiologist. POLYENES ' Associate Professor, Microbiologist. ' Associate Professor, Chemist. With the exceptions of griseofulvin and variotin, ' The literature on this subject has been extensively are all the reviewed by Waksman & Lechevalier (1962), Waksman (1963) which produced by fungi, nearly important and kehiek (1964). antifungal antibiotics are produced by actinomycetes 1638 -219- 220 S. A. WAKSMAN, H. A. LECHEVALIER & C. P. SCHAFFNER and are polyenic in nature. Among the important pentamycin, filipin, lagosin, moldcidin, and aliomy- non-polyenic products, one should mention cyclo- cin. None of these has so far found any practical heximide, an actinomycetic product mainly used application. against plant pathogens. The polyenes possess similar chemical properties (Drouhet, 1958), but they can be largely distin- Hexaenes guished by their characteristic light-absorption Flavacid was the first hexaene obtained from a spectra. This is due to the presence in the molecule culture of Streptomyces flavus (Takahashi, 1953). of a series of conjugated unsaturated double bonds Among the other known hexaenes, one may mention (Oroshnik et al., 1955). They are unstable com- mediocidin, endomycin, and cryptocidin. None of pounds, especially in the light and in acidic or them has been highly purified and none has found alkaline solutions. They are not readily soluble in practical application. non-polar solvents or in water. Their high activity upon pathogenic yeasts and yeast-like fungi tended to render these antibiotics extremely valuable in Heptaenes the treatment of various fungal infections in man This group of polyenic antibiotics contains some and in animals not otherwise subject to therapy. of the most important antifungal agents that have The recent extensive use of tetracyclines in human found application in human and animal therapy. and animal therapy tends to favour moniliasis and Candicidin, Trichomycin and ascosin were the other infections due to yeast-like fungi. This further earliest reported. Later amphotericin B and candi- necessitated the use of polyenes for the treatment of din, and, more recently, hamycin were isolated and such secondary infections. The polyenes are usually found to be highly effective. A number of other produced by cultures of actinomycetes, some of heptaenes have been isolated, such as perimycin, which also form other antibiotics. heptamycin and various others, designated by letter Nearly 50 polyene antibiotics have now been or by number. isolated, many of which have been crystallized. On The candicidin-producing culture (a strain of the basis of their absorption of light, they are usually Streptomyces griseus) was first isolated in 1948 from separated into four major subgroups, based upon a sample of cow manure (Lechevalier et al., 1953). the presence of a chain of four, five, six or seven An antibiotic preparation obtained from this culture conjugated double bonds. Their chemical and (C135) was highly active upon yeasts and yeast-like biological properties have been summarized in fungi, but not upon filamentous fungi, and had no various reports (Neelameghan, 1960; Vining, 1960; activity upon bacteria. It was named candicidin Drouhet, 1963). because of its high activity on Candida albicans. Candicidin was found to be similar, in its light- Tetraenes absorption spectrum, to ascosin, but was quite Fungicidin, later designated as nystatin, is a distinct from nystatin, antimycoin, chromin, and tetraene. It was the first polyenic antibiotic isolated rimocidin. Further studies (Vining et al., 1954) (Hazen & Brown, 1950) from a culture of Strepto- brought out the fact that candicidin was closely myces noursei. It found extensive practical applica- related to ascosin (Hickey et al., 1952), and tricho- tion in the treatment of monilial and other infections mycin (Hosoya et al., 1952). Another antibiotic, caused by yeast-like fungi (Dutcher, 1957; Lampen, candidin (Vining et al., 1955), also isolated in our 1962). Other tetraene antibiotics later isolated laboratory, differed from the ascosin-candicidin- include rimocidin, chromin, antimycoin, sistomy- Trichomycin type. A comparison of four polyenes cosin, pimaricin, etruscomycin, unamycin, protoci- pointed to a very high activity of candicidin (see dine, and akitamycin. None of these has found, so the table). far as is known, any practical application. These four polyenes, when tested on a solid medium, were more active against growing fungi at Pentaenes a neutral pH than at an acid pH. In a liquid medium, Eurocidin was probably the first pentaene isolated differences in activity at various pH values were (Nakazawa, 1955) from actinomycete cultures. less striking. The activity of candicidin varied with Among the other pentaenes now known, mention pH more than that of the other three polyenes. may be made of fungichromin, fungichromatin, Nystatin was least affected by pH variations. CANDICIDIN AND OTHER POLYBNIC ANTIFUNGAL ANTIBIOTICS 221 EFFECT OF FOUR POLYENIC ANTIFUNGAL ANTIBIOTICS AT TWO DIFFERENT pH VALUES a Minimum Inhibitory concentration b (<g/mI) AntUbIotic C. albkans S. cerevislae A. niger pH 4.5 pH 7.0 Rati pH4.5/0 pH 4.5 pH 7.0 pH 4.5 pH 7.0 Nystatin 4.5 1.6 2.8 5.7 1.7 Candidin 0.5 0.12 4.2 0.40 0.11 Amphotericin B 0.5 0.15 3.3 0.43 0.09 Candicidin 0.057 0.005 11.5 0.025 0.001 0.7 0.1 a Reproduced, by permisslon, from Lechevaller (1960). b Average of three assays. IN VIVO ACTIVITIES OF POLYENE ANTIBIOTICS Fungimycin (syn. perimycin) was isolated in 1952 in crude form by Wooldridge and Hoffmann from a The polyenes conform to a general pattern of culture later designated as S. coelicolor var. amino- toxicity and antimicrobial activity, exhibiting varying philus. Further chemical investigations (Borowski degrees of action against many species of fungi et al., 1960) showed it to be a unique member of the (Gerke & Madigan, 1961). They have no effect upon aromatic subgroup of heptaene antibiotics. the growth of bacteria, but in some cases they are active against certain protozoa (Furtado, 1960). Amphotericin was isolated (Gold et
Recommended publications
  • Topical and Systemic Antifungal Therapy for Chronic Rhinosinusitis (Protocol)
    CORE Metadata, citation and similar papers at core.ac.uk Provided by University of East Anglia digital repository Cochrane Database of Systematic Reviews Topical and systemic antifungal therapy for chronic rhinosinusitis (Protocol) Head K, Sacks PL, Chong LY, Hopkins C, Philpott C Head K, Sacks PL, Chong LY, Hopkins C, Philpott C. Topical and systemic antifungal therapy for chronic rhinosinusitis. Cochrane Database of Systematic Reviews 2016, Issue 11. Art. No.: CD012453. DOI: 10.1002/14651858.CD012453. www.cochranelibrary.com Topical and systemic antifungal therapy for chronic rhinosinusitis (Protocol) Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. TABLE OF CONTENTS HEADER....................................... 1 ABSTRACT ...................................... 1 BACKGROUND .................................... 1 OBJECTIVES ..................................... 3 METHODS ...................................... 3 ACKNOWLEDGEMENTS . 8 REFERENCES ..................................... 9 APPENDICES ..................................... 10 CONTRIBUTIONSOFAUTHORS . 25 DECLARATIONSOFINTEREST . 26 SOURCESOFSUPPORT . 26 NOTES........................................ 26 Topical and systemic antifungal therapy for chronic rhinosinusitis (Protocol) i Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. [Intervention Protocol] Topical and systemic antifungal therapy for chronic rhinosinusitis Karen Head1, Peta-Lee Sacks2, Lee Yee Chong1, Claire Hopkins3, Carl Philpott4 1UK Cochrane Centre,
    [Show full text]
  • THE INFLUENCE of SOME ANTIFUNGAL ANTIBIOTICS on NEUROMUSCULAR TRANSMISSION B.L
    THE INFLUENCE OF SOME ANTIFUNGAL ANTIBIOTICS ON NEUROMUSCULAR TRANSMISSION B.l M. SIRSI Pharmacology Laboratory, Indian Institute of Science, Bangalore, 12. (Received January 25, 1963) The influcncc of the polyene antifungal antibiotics pimaricin, amphotericin A and B and nystatin, on neuromuscular transmission has been studied. In presence of these antibiotics both direct and indirect electrical stimulation is found. to cause varying degrees of contracture and diminished excitability of the musculature. This is in contrast to the effect of Hamycin, another polyene antibiotic which produces loss of excitability without any initial contracture of the diaphragm. Certain antibiotics have been shown to produce neuromuscular block, both in experimental animals and in humaps. Intraperitoneal administra- tion of neomycin has been followed by respiratory insufficiency or apnoea; streptomycin has caused neuromuscular block in experimental animals and in interccstal nerve preparations of human and is strongly incriminated in causing the muscular weakness and visual difficulty as also post-operative paralysis by neuromuscular blockage (Fisk, 1961, Bush, 1961). Polymyxin B is also reported to exhibit blocking action on the muscle end plate (Sabawala and Dillon, 1959). The following communication deals with the effect of certain antifungal antibiotics on the neuromuscular junction as studied by the rat phrenic nerve diaphragm preparations. METHODS The antibiotics studied were, pimaricin, amphotericin A and B, and nystatin. Their effects have been compared with those of hamycin reported earlier (Sirsi, 1963). -- The required concentrations of the antibiotics were prepared in propylene glycol and further dilutions in water. Phrenic nerve diaphragm preparations were made as described by Bulbring (1916) and were suspended in abath of 75 ml of aerated Tyrode's solution which contained twice the amount of glucose as stated in original M.
    [Show full text]
  • Title 16. Crimes and Offenses Chapter 13. Controlled Substances Article 1
    TITLE 16. CRIMES AND OFFENSES CHAPTER 13. CONTROLLED SUBSTANCES ARTICLE 1. GENERAL PROVISIONS § 16-13-1. Drug related objects (a) As used in this Code section, the term: (1) "Controlled substance" shall have the same meaning as defined in Article 2 of this chapter, relating to controlled substances. For the purposes of this Code section, the term "controlled substance" shall include marijuana as defined by paragraph (16) of Code Section 16-13-21. (2) "Dangerous drug" shall have the same meaning as defined in Article 3 of this chapter, relating to dangerous drugs. (3) "Drug related object" means any machine, instrument, tool, equipment, contrivance, or device which an average person would reasonably conclude is intended to be used for one or more of the following purposes: (A) To introduce into the human body any dangerous drug or controlled substance under circumstances in violation of the laws of this state; (B) To enhance the effect on the human body of any dangerous drug or controlled substance under circumstances in violation of the laws of this state; (C) To conceal any quantity of any dangerous drug or controlled substance under circumstances in violation of the laws of this state; or (D) To test the strength, effectiveness, or purity of any dangerous drug or controlled substance under circumstances in violation of the laws of this state. (4) "Knowingly" means having general knowledge that a machine, instrument, tool, item of equipment, contrivance, or device is a drug related object or having reasonable grounds to believe that any such object is or may, to an average person, appear to be a drug related object.
    [Show full text]
  • 1.Development and Validation Of
    International Journal Of Advanced Research In Medical & Pharmaceutical Sciences (IJARMPS-ISSN-2455-6998) Volume.4,Issue.12,December.2019 DEVELOPMENT AND VALIDATION OF KETOCONAZOLE BY RP-HPLC MOODU BALU*,Dr. SANJEEV KUMAR SUBUDHI,SHAIK ZUBAIR, S. NAVYA, RUHEENA NAAZ, SIRIMALLA.MOUNIKA. Department of Pharmaceutical Analysis, Talla padmavathi pharmacy college , urus, kareemabad, warangal,506002. ABSTRACT : The objective of the present research work was to develop a innovative, simple, and economic method for estimation of Ketoconazole in bulk and dosage form by RP-HPLC.The chromatographic conditions were performed on Phenomenex Luna C18, 100A, 5µm, 250mmx4.6mm i.d.as stationary phase and mobile phase was prepared with a mixture of Acetonitrile : 0.2% triethylamine (pH-6.5) = 70:30 (pH-6.5) flow 1.0 ml/min, with Injection Volume 10µl, at detection wavelength 243 nm and run time at 5.0 min.The analytical method is valid for estimation of Ketoconazole over a range of 10µg/ml–50 µg/ml. The results of system suitability test, linearity, precision and accuracy, robustness, specificity, LOD and LOQ and stabilities presented in this report are within the acceptance range.A specific, sensitive, economic method estimation of Ketoconazole has been developed based on ICH Guidelines with bulk and dosage forms. Key Words: Ketoconazole , HPLC, Method Development, ICH, Validation, Accuracy, Precision. I.INTRODUCTION Ketoconazole is a lipophilic imidazole derivative appears as white to off white crystalline powder. The drug is not miscible in water, miscible in strong bases and soluble to a low extent in strong acid, having molecular weight of 531.44. It is a feeble base, having acid dissociation constant values of 6.51 and 2.94, it contains five- membered azole ring emboding two nitrogen atoms.[1-4] It is a chiral drug containing a racemic (1:1) mixture of enantiomers of the cis configuration.
    [Show full text]
  • Safety, Tolerability and Pharmacokinetics of Intravaginal Pentamycin
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by edoc Pharmacology Chemotherapy 2010;56:190–196 Received: March 20, 2009 DOI: 10.1159/000316329 Accepted after revision: January 12, 2010 Published online: June 10, 2010 Safety, Tolerability and Pharmacokinetics of Intravaginal Pentamycin a a c b B. Frey Tirri J. Bitzer B. Geudelin J. Drewe a b Departments of Obstetrics and Gynecology, and Clinical Pharmacology, University Hospital Basel, and c Mediante GmbH, Basel , Switzerland Key Words cin does not cause adverse reactions compared with vehicle -Antimicrobial agents ؒ Pentamycin ؒ Pharmacokinetics ؒ and is not absorbed through the intact or the inflamed va Polyene antifungal antibiotic ؒ Vaginal infections gina. Copyright © 2010 S. Karger AG, Basel Abstract Background/Aims: Intravaginal pentamycin is a polyene Introduction macrolide with a broad spectrum of antimicrobial activity and is effective in various forms of infectious vaginitis. We The most common vaginal disorders include vaginal evaluated the safety, tolerability and pharmacokinetics of candidiasis, vaginal trichomoniasis and bacterial vagino- escalating doses of this product. Methods: Nineteen healthy sis [1–5] . Forms of infectious vaginitis sustained by mixed volunteers were randomized to receive double blind one of micro-organisms are also observed frequently [6] . Vagi- five doses of intravaginal pentamycin (3, 10, 30, 60 or 100 mg) nal infections can be successfully treated by using one or or the corresponding dose of pentamycin vehicle daily for more pathogen-specific antimicrobials [1, 3, 7–9] , but, be- 6 days. Patients with symptomatic vaginitis received a single fore vaginitis is treated, the cause must be ascertained by dose of 60 (n = 6) or 100 mg (n = 6) of intravaginal penta- using appropriate laboratory tests [1, 2, 6, 7, 10] .
    [Show full text]
  • Pharmaceuticals As Environmental Contaminants
    PharmaceuticalsPharmaceuticals asas EnvironmentalEnvironmental Contaminants:Contaminants: anan OverviewOverview ofof thethe ScienceScience Christian G. Daughton, Ph.D. Chief, Environmental Chemistry Branch Environmental Sciences Division National Exposure Research Laboratory Office of Research and Development Environmental Protection Agency Las Vegas, Nevada 89119 [email protected] Office of Research and Development National Exposure Research Laboratory, Environmental Sciences Division, Las Vegas, Nevada Why and how do drugs contaminate the environment? What might it all mean? How do we prevent it? Office of Research and Development National Exposure Research Laboratory, Environmental Sciences Division, Las Vegas, Nevada This talk presents only a cursory overview of some of the many science issues surrounding the topic of pharmaceuticals as environmental contaminants Office of Research and Development National Exposure Research Laboratory, Environmental Sciences Division, Las Vegas, Nevada A Clarification We sometimes loosely (but incorrectly) refer to drugs, medicines, medications, or pharmaceuticals as being the substances that contaminant the environment. The actual environmental contaminants, however, are the active pharmaceutical ingredients – APIs. These terms are all often used interchangeably Office of Research and Development National Exposure Research Laboratory, Environmental Sciences Division, Las Vegas, Nevada Office of Research and Development Available: http://www.epa.gov/nerlesd1/chemistry/pharma/image/drawing.pdfNational
    [Show full text]
  • United States Patent 19 [11] 3,957,754 Aszalos Et Al
    United States Patent 19 [11] 3,957,754 ASzalos et al. (45) May 18, 1976 54 COMPLEXES OF ANTIFUNGAL POLYENE 3,777,018 12/1973 Gordon et al................ 260/210 AB ANTIBOTCS FOREIGN PATENTS OR APPLICATIONS (75) Inventors: Adorjan Aszalos, Princeton; John Vandeputte, Milltown, both of N.J. 795,482 5/1958 United Kingdom.......... 260/210 AB (73) Assignee: E. R. Squibb & Sons, Inc., OTHER PUBLICATIONS Princeton, N.J. 22 Filed: Jan. 13, 1975 Mazor et al. “Chem. Abst." Vol. 57, 1962, p. 956g. 21 Appl. No.: 540,750 Primary Examiner-Johnnie R. Brown Related U.S. Application Data Attorney, Agent, or Firm-Lawrence S. Levinson; 62 Division of Ser. No. 100,492, Dec. 21, 1970, Pat. No. Merle J. Smith; Stephen B. Davis 3,879,374. 52 U.S. Cl........................... 260/210 AB; 424/180; 57) ABSTRACT 424/181 51 int. Cl'.......................................... C07H 15/20 Disclosed herein are complexes of polyene antibiotics 58 Field of Search.............. 260/210 AB; 424/117, which are soluble in alcohol or in water and alcohol. 424/119 These complexes are prepared in alcoholic solutions and have been found to be useful as antifungal agents 56) References Cited which can be orally administered. UNITED STATES PATENTS 6 Claims, No Drawings 2,865,807 12, 1958 Dutcher et al............... 260/20 AB 3,957,754 2 Alcohols that can be utilized to carry out the reaction COMPLEXES OF ANTIFUNGAL POLYENE are the lower alkyl alcohols of from 1 to 6 carbons such ANTBIOTICS as methanol, ethanol, isopropanol, isobutanol, butanol, This is a division of Ser.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 6,767,552 B2 Narang (45) Date of Patent: Jul
    USOO6767552B2 (12) United States Patent (10) Patent No.: US 6,767,552 B2 Narang (45) Date of Patent: Jul. 27, 2004 (54) ADHESIVE TREATMENT FOR ORAL 5.530,037 A 6/1996 McDonnell et al. FUNGAL INFECTION 5,554,365 A 9/1996 Byram et al. 5,575.997 A 11/1996 Leung et al. (75) Inventor: Upvan Narang, Raleigh, NC (US) 5,580,565 A 12/1996 Tighe et al. 5,582,834 A 12/1996 Leung et al. (73) Assignee: Closure Medical Corporation, 5,613,942 A 3/1997 Lucast et al. Raleigh, NC (US) 5,624,669 A 4/1997 Leung et al. 9, 5,653,769 A 8/1997 Barley, Jr. et al. 5,661,170 A 8/1997 Chodosh (*) Notice: Subject to any disclaimer, the term of this 5,665,817 A 810: E. al. patent is extended or adjusted under 35 5,684,042 A 11/1997 Greff et al. U.S.C. 154(b) by 359 days. 5,716,607 A 2/1998 Byram et al. 5,717.005 A 2/1998 Richardson (21) Appl. No.: 09/898,092 5,725,491 A 3/1998 Tipton et al. 5,730,994. A 3/1998 Askill et al. (22) Filed: Jul. 5, 2001 5,753,699 A 5/1998 Greff et al. 5,755,680 A 5/1998 Ghodsian (65) Prior Publication Data 5,762.919 A 6/1998 Greff et al. 5,762.955 A 6/1998 Smith US 2003/0007947 A1 Jan. 9, 2003 5,783,177 A 7/1998 Greff et al.
    [Show full text]
  • 296 Results and Discussion. the Clinical Presentation of Cutaneous
    Results and discussion. The clinical presentation of cutaneous candidiasis can vary depending on the type of infection and the degree of immunosuppression. Most ofen, a pruritic red rash develops. Physical examination reveals a rash that begins with vesiculopustules that enlarge and rupture, causing maceration and fissuring. The area involved has a scalloped border with a white rim consisting of necrotic epidermis that surrounds the erythematous macerated base. Paronychia and onychomycosis are frequently associated with immersion of the hands in water and with diabetes mellitus. Most localized cutaneous candidiasis infections may be treated of topical antifungal agents. In cases of extensive cutaneous infections, infections in immunocompromised patients, folliculitis, or onychomycosis, systemic antifungal therapy is recommended. Topical antifungal agents include polyene antibiotics: amphotericin B, nystatin, hamycin, natamycin; azoles: bifonazole, clotrimazole, econazole, ketoconazole, miconazole, oxiconazole, sertaconazole; allylamines, for examples, terbinafine; other topical agents: undecyclinic acid, ciclopirox and etc. Systemic antifungal drugs include allylamines (terbinafine), polyene antibiotics (amphotericin B, nystatin, levorin), pyrimidine antibiotics (flucytosine). Of the clinically employed azole antifungals, only a handful are used systemically. These include ketoconazole, itraconazole, fluconazole and etc. Conclusion. Thus, we studied and analyzed modern standards of medical care for patients with cutaneous candidiasis, according to which the treatment of cutaneous candidiasis includes the use of local and systemic antifungal drugs. CURRENT TRENDS IN THE USE OF 1, 4-BENZODIAZEPINE DERIVATIVES IN MEDICAL PRACTICE Botsula I.V. Scientific supervisor: Kireyev I.V. National University of Pharmacy, Kharkiv, Ukraine [email protected] Introduction. Despite the fact that anxiety is a normal reaction of the body to the action of environmental factors, yet with chronic manifestations, it can significantly impair the quality of life.
    [Show full text]
  • Alphabetical Listing of ATC Drugs & Codes
    Alphabetical Listing of ATC drugs & codes. Introduction This file is an alphabetical listing of ATC codes as supplied to us in November 1999. It is supplied free as a service to those who care about good medicine use by mSupply support. To get an overview of the ATC system, use the “ATC categories.pdf” document also alvailable from www.msupply.org.nz Thanks to the WHO collaborating centre for Drug Statistics & Methodology, Norway, for supplying the raw data. I have intentionally supplied these files as PDFs so that they are not quite so easily manipulated and redistributed. I am told there is no copyright on the files, but it still seems polite to ask before using other people’s work, so please contact <[email protected]> for permission before asking us for text files. mSupply support also distributes mSupply software for inventory control, which has an inbuilt system for reporting on medicine usage using the ATC system You can download a full working version from www.msupply.org.nz Craig Drown, mSupply Support <[email protected]> April 2000 A (2-benzhydryloxyethyl)diethyl-methylammonium iodide A03AB16 0.3 g O 2-(4-chlorphenoxy)-ethanol D01AE06 4-dimethylaminophenol V03AB27 Abciximab B01AC13 25 mg P Absorbable gelatin sponge B02BC01 Acadesine C01EB13 Acamprosate V03AA03 2 g O Acarbose A10BF01 0.3 g O Acebutolol C07AB04 0.4 g O,P Acebutolol and thiazides C07BB04 Aceclidine S01EB08 Aceclidine, combinations S01EB58 Aceclofenac M01AB16 0.2 g O Acefylline piperazine R03DA09 Acemetacin M01AB11 Acenocoumarol B01AA07 5 mg O Acepromazine N05AA04
    [Show full text]
  • A Decade of Antifungal Leads from Natural Products: 2010–2019
    pharmaceuticals Review A Decade of Antifungal Leads from Natural Products: 2010–2019 Mohammed Aldholmi 1,2 , Pascal Marchand 3 , Isabelle Ourliac-Garnier 3 , Patrice Le Pape 3 and A. Ganesan 2,* 1 Department of Natural Products and Alternative Medicine, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia; [email protected] 2 School of Pharmacy, University of East Anglia, Norwich Research Park, Norwich NR4 7TJ, UK 3 Université de Nantes, Cibles et Médicaments des Infections et du Cancer, IICiMed, EA 1155, F-44000 Nantes, France; [email protected] (P.M.); [email protected] (I.O.-G.); [email protected] (P.L.P.) * Correspondence: [email protected] Received: 29 November 2019; Accepted: 10 December 2019; Published: 12 December 2019 Abstract: In this review, we discuss novel natural products discovered within the last decade that are reported to have antifungal activity against pathogenic species. Nearly a hundred natural products were identified that originate from bacteria, algae, fungi, sponges, and plants. Fungi were the most prolific source of antifungal compounds discovered during the period of review. The structural diversity of these antifungal leads encompasses all the major classes of natural products including polyketides, shikimate metabolites, terpenoids, alkaloids, and peptides. Keywords: fungal pathogens; antifungal agents; natural products 1. Introduction The global increase in antimicrobial resistance among pathogenic bacteria, viruses, fungi, and parasites is a serious concern for human healthcare. In the case of fungi, more than one billion individuals worldwide are affected by fungal infections and the associated mortality, over 1.5 million deaths each year, is equivalent to that caused by tuberculosis and more than triple that of malaria [1].
    [Show full text]
  • Natamycin As an Allowed Nonsynthetic Substance
    Technology Sciences Group Inc. 712 Fifth St., Suite A Davis, CA 95616 Direct: (530) 601-5064 Fax: (530) 757-1299 E-Mail: [email protected] Jacob S. Moore Regulatory Consultant September 1, 2016 USDA/AMS/NOP, Standards Division 1400 Independence Ave. SW Room 2648-So., Ag Stop 0268 Washington, DC 20250-0268 Attention: Lisa Brines, PhD National List Manager RE: National Organic Program Petition for Classification of Natamycin as an Allowed Nonsynthetic Substance Dear Dr. Brines: Technology Sciences Group Inc., on behalf of DSM Food Specialties B.V., submits the enclosed petition for classification of natamycin as an allowed nonsynthetic substance. Natamycin is a naturally-occurring compound produced by fermentation of Streptomyces natalensis. As natamycin is known to the National Organic Program and National Organic Standards Board, the petitioner requests that a focused Technical Report be issued to complement the work previously done and resolve the classification status of the petitioned substance. Please contact me with any questions or concerns. Jacob S. Moore TITLE Petition for Classification of Natamycin as an Allowed Nonsynthetic Substance in Organic Crop Production AUTHOR Technology Sciences Group Inc. DATE September 1, 2016 Page 1 of 212 Natamycin Allowed Nonsynthetic Petition – National Organic Program – September 1, 2016 Table of Contents Item A—Indicate which section or sections the petitioned substance will be included on and/or removed from the National List. .................................................................................................................................
    [Show full text]